Jefferies Group LLC Guardant Health, Inc. Put Options Transaction History

Jefferies Group LLC

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Sep 21, 2023	SELL	$43.66 - $61.0 $2.26 Million - $3.15 Million	-51,700 Reduced 41.86%	71,800 $3.86 Million
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $2.26 Million - $3.15 Million	-51,700 Reduced 41.86%	71,800 $3.87 Million
Q2 2022 Sep 21, 2023	BUY	$28.82 - $77.35 $2.71 Million - $7.27 Million	94,000 Added 318.64%	123,500 $4.98 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $2.71 Million - $7.27 Million	94,000 Added 318.64%	123,500 $4.98 Million
Q4 2021 Sep 21, 2023	BUY	$88.71 - $120.43 $2.48 Million - $3.37 Million	28,000 Added 1866.67%	29,500 $2.95 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $2.48 Million - $3.37 Million	28,000 Added 1866.67%	29,500 $2.95 Million
Q3 2021 Sep 21, 2023	SELL	$98.77 - $132.17 $1.56 Million - $2.09 Million	-15,800 Reduced 91.33%	1,500 $187,000
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $1.56 Million - $2.09 Million	-15,800 Reduced 91.33%	1,500 $188,000
Q2 2021 Sep 21, 2023	BUY	$109.77 - $165.68 $164,655 - $248,520	1,500 Added 9.49%	17,300 $2.15 Million
Q2 2021 Aug 20, 2021	SELL	$109.77 - $165.68 $188 Million - $284 Million	-1,712,700 Reduced 99.0%	17,300 $2.15 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $188 Million - $284 Million	1,714,200 Added 10849.37%	1,730,000 $2.15 Million
Q1 2021 Sep 21, 2023	SELL	$127.04 - $179.1 $7.11 Million - $10 Million	-56,000 Reduced 77.99%	15,800 $2.41 Million
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $2.01 Million - $2.83 Million	15,800 New	15,800 $2.41 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.